USA-based firm SAS, a business intelligence company, has released new technology for managing research information, known as the SAS Clinical Data Integration Server Platform, in the UK.
The firm claims the software enables organizations to to more easily bring together internal and external research data in order to conduct analyses. Also the platform will allow companies to improve quality and timeliness while maintaining industry standards and eliminating redundant operations, according to SAS.
For further information, visit the company's web site at: www.sas.com/uk.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze